These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 15372629)

  • 21. A kunitz-type protease inhibitor bikunin disrupts ligand-induced oligomerization of receptors for transforming growth factor (TGF)-beta and subsequently suppresses TGF-beta signalings.
    Yagyu T; Kobayashi H; Wakahara K; Matsuzaki H; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
    FEBS Lett; 2004 Oct; 576(3):408-16. PubMed ID: 15498571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of transforming growth factor-β1 on plasminogen activation in stem cells from the apical papilla: role of activating receptor-like kinase 5/Smad2 and mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signalling.
    Chang MC; Chang HH; Hsieh WC; Huang WL; Lian YC; Jeng PY; Wang YL; Yeung SY; Jeng JH
    Int Endod J; 2020 May; 53(5):647-659. PubMed ID: 31955434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERK contributes to the effects of Smad signaling on oxidized LDL-induced PAI-1 expression in human mesangial cells.
    Hong HK; Song CY; Kim BC; Lee HS
    Transl Res; 2006 Oct; 148(4):171-9. PubMed ID: 17002919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombospondin-1 and transforming growth factor beta-1 upregulate plasminogen activator inhibitor type 1 in pancreatic cancer.
    Albo D; Berger DH; Vogel J; Tuszynski GP
    J Gastrointest Surg; 1999; 3(4):411-7. PubMed ID: 10482694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks.
    Samarakoon R; Higgins PJ
    J Cell Sci; 2002 Aug; 115(Pt 15):3093-103. PubMed ID: 12118065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.
    Hayashida T; Schnaper HW
    J Am Soc Nephrol; 2004 Aug; 15(8):2032-41. PubMed ID: 15284289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
    Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
    Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of PAI-1 is mediated through TGF-beta/Smad pathway in transplant arteriopathy.
    Dong C; Zhu S; Wang T; Yoon W; Goldschmidt-Clermont PJ
    J Heart Lung Transplant; 2002 Sep; 21(9):999-1008. PubMed ID: 12231371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone deacetylase inhibitor m-carboxycinnamic acid bis-hydroxamide attenuates plasminogen activator inhibitor-1 expression in human pleural mesothelial cells.
    Chung CL; Sheu JR; Chen WL; Chou YC; Hsiao CJ; Hsiao SH; Hsu MJ; Cheng YW; Hsiao G
    Am J Respir Cell Mol Biol; 2012 Apr; 46(4):437-45. PubMed ID: 22033265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta1 induces tissue inhibitor of metalloproteinase-1 expression via activation of extracellular signal-regulated kinase and Sp1 in human fibrosarcoma cells.
    Kwak HJ; Park MJ; Cho H; Park CM; Moon SI; Lee HC; Park IC; Kim MS; Rhee CH; Hong SI
    Mol Cancer Res; 2006 Mar; 4(3):209-20. PubMed ID: 16547158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
    Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
    Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
    Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
    Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1.
    Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31382626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.